Search Results - "Karino, Y."

Search for Majorana Neutrinos Near the Inverted Mass Hierarchy Region with KamLAND-Zen by Gando, A, Gando, Y, Hachiya, T, Hayashi, A, Hayashida, S, Ikeda, H, Inoue, K, Ishidoshiro, K, Karino, Y, Koga, M, Matsuda, S, Mitsui, T, Nakamura, K, Obara, S, Oura, T, Ozaki, H, Shimizu, I, Shirahata, Y, Shirai, J, Suzuki, A, Takai, T, Tamae, K, Teraoka, Y, Ueshima, K, Watanabe, H, Kozlov, A, Takemoto, Y, Yoshida, S, Fushimi, K, Banks, T I, Berger, B E, Fujikawa, B K, O'Donnell, T, Winslow, L A, Efremenko, Y, Karwowski, H J, Markoff, D M, Tornow, W, Detwiler, J A, Enomoto, S, Decowski, M P

“…We present an improved search for neutrinoless double-beta (0νββ) decay of ^{136}Xe in the KamLAND-Zen experiment. Owing to purification of the xenon-loaded…”
Get full text

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C by Karino, Y., Ozeki, I., Hige, S., Kimura, M., Arakawa, T., Nakajima, T., Kuwata, Y., Sato, T., Ohmura, T., Toyota, J.

“…Summary We aimed to examine the relationship between renal dysfunction and anaemia that may develop during combination therapy involving pegylated interferon,…”
Get full text

Analysis of Hepatitis B Surface Antigen (HBsAg) Levels Using the Highly Sensitive Lumipulse HBsAg-HQ Assay in Hepatitis B Virus Patients with HBsAg Seroclearance According to the Conventional Assay by Ozeki, I, Nakajima, T, Hige, S, Karino, Y, Toyota, J

Get full text

P0997 : WFA+-M2BP is a predictive factor for fibrosis progression in NAFLD by Nakajima, T, Ozeki, I, Hige, S, Karino, Y, Toyota, J

Get full text

Clinical Impact of Asymptomatic HEV Infection Proven by Screeng on Blood Donation in Hokkaido, Japan by Kang, J.-H, Yamamoto, Y, Karino, Y, Watanebe, M, Yoshizaki, N, Katsuki, S.-I, Matsubayashi, K

Get full text

CERTAIN-1: efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis by Chayama, K, Suzuki, F, Karino, Y, Kawakami, Y, Sato, K, Atarashi, T, Naganuma, A, Watanabe, T, Eguchi, Y, Yoshiji, H, Seike, M, Takei, Y, Kato, K, Alves, K, Burroughs, M, Redman, R, Pugatch, D.L, Pilot-Matias, T, Xie, W, Kumada, H

Get full text

The Real World Experience of Daclatasvir and Asunaprevir Combination Therapy for More Elderly Patients thanthe Clinical Trial Subjects with Genotype 1b Chronic Hepatitis C by Hige, S, Karino, Y, Ozeki, I, Yamaguchi, M, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J

Get full text

G13 : Ombitasvir/paritaprevir/ritonavir for treatment of HCV genotype 1b in Japanese patients with or without cirrhosis: Results from gift-I by Chayama, K, Suzuki, F, Ikeda, K, Toyoda, H, Sato, K, Karino, Y, Matsuzaki, Y, Kioka, K, Pilot-Matias, T, Setze, C, Zhang, X, Badri, P, Yanke, T, Matsuda, T, Vilchez, R.A, Rodrigues-Jr, L, Kumada, H

Get full text

Publisher's Note: Search for Majorana Neutrinos Near the Inverted Mass Hierarchy Region with KamLAND-Zen [Phys. Rev. Lett. 117, 082503 (2016)] by Gando, A, Gando, Y, Hachiya, T, Hayashi, A, Hayashida, S, Ikeda, H, Inoue, K, Ishidoshiro, K, Karino, Y, Koga, M, Matsuda, S, Mitsui, T, Nakamura, K, Obara, S, Oura, T, Ozaki, H, Shimizu, I, Shirahata, Y, Shirai, J, Suzuki, A, Takai, T, Tamae, K, Teraoka, Y, Ueshima, K, Watanabe, H, Kozlov, A, Takemoto, Y, Yoshida, S, Fushimi, K, Banks, T I, Berger, B E, Fujikawa, B K, O'Donnell, T, Winslow, L A, Efremenko, Y, Karwowski, H J, Markoff, D M, Tornow, W, Detwiler, J A, Enomoto, S, Decowski, M P

“…This corrects the article DOI: 10.1103/PhysRevLett.117.082503…”
Get full text

825 ANALYSIS OF THE OPTIMAL TVR DOSE PER WEIGHT JUDGING FROM ANEMIA DURING PEG-IFN/RBV/TVR COMBINATION THERAPY by Karino, Y, Ozeki, I, Hige, S, Toyota, J, Imamura, M, Tsuge, M, Chayama, K, Akuta, N, Suzuki, F, Kumada, H

Get full text

1234 REEMERGING HEPATITIS E EPIDEMIC IN SAPPORO, JAPAN, CAUSED BY A MONOPHYLETIC AND VIRULANT HEV STRAIN WITHIN GENOTYPE 4 by Kang, J.-H, Karino, Y, Mizuo, H, Takahashi, K, Arai, M, Okamoto, H, Mishiro, S

Get full text

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b by Toyota, J., Ozeki, I., Karino, Y., Asahina, Y., Izumi, N., Takahashi, S., Kawakami, Y., Chayama, K., Kamiya, N., Aoki, K., Yamada, I., Suzuki, Y., Suzuki, F., Kumada, H.

“…Hepatitis C virus (HCV) subtype 1b, which infects approximately 70% of Japanese carriers, is likely to be more eradicable by a telaprevir regimen than subtype…”
Get full text

1124 2250MG/DAY OF TELAPREVIR DOSAGE IMPAIR THE RIBAVIRIN DOSAGE AND CLINICAL EFFECT OF TRIPLE THERAPY IN THE PATIENTS WITH A LOW TOTAL CLEARANCE OF RIBAVIRIN by Karino, Y, Nakajima, T, Ozeki, I, Toyota, J, Imamura, M, Tsuge, M, Chayama, K, Akuta, N, Suzuki, F, Kumada, H

Get full text

835 RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TVR COMBINATION THERAPY IS A GOOD PREDICTIVE MARKER OF RENAL DYSFUNCTION AND ANEMIA by Karino, Y, Ozeki, I, Hige, S, Miyakawa, M, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J

Get full text

1252 INCREASING INCIDENCE OF LOCALLY ACQUIRED HEPATITIS E IN HOKKAIDO, THE MOST ENDEMIC AREA IN JAPAN by Kang, J.-H, Karino, Y, Mizuo, H, Okamoto, H, Mishiro, S

Get full text

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus by Kaneto, H, Sasaki, S, Yamamoto, H, Itoh, F, Toyota, M, Suzuki, H, Ozeki, I, Iwata, N, Ohmura, T, Satoh, T, Karino, Y, Toyota, J, Satoh, M, Endo, T, Omata, M, Imai, K

“…Inactivation of the p16(INK4A) (p16) tumour suppressor gene by promoter region hypermethylation has been demonstrated not only in many types of tumours,…”
Get full text

14 DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRIN by Suzuki, F, Ikeda, K, Toyota, J, Karino, Y, Ohmura, T, Chayama, K, Takahashi, S, Kawakami, Y, Ishikawa, H, Watanabe, H, Hu, W, McPhee, F, Hughes, E, Kumada, H

Get full text

1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY by Karino, Y, Ozeki, I, Toyota, J, Imamura, M, Tsuge, M, Chayama, K, Sezaki, H, Akuta, N, Kumada, H

Get full text

Effect of wheel-slip prevention based on sliding mode control theory for railway vehicles by Yamazaki, H., Karino, Y., Kamada, T., Nagai, M., Kimura, T.

“…It is important to consider the robustness when designing brake control systems, because of the model's uncertainties that result from the nonlinear…”
Get full text

268 RELATIONSHIP OF SERUM IP-10 LEVELS WHICH REFLECTS HEPATIC INTERFERON STIMULATING GENE INDUCTION AND ANTIVIRAL EFFECT OF PEG/RBV COMBINATION THERAPY IN PATIENT WITH CHRONIC HEPATITIS C by Karino, Y, Toyota, J, Arakawa, T, Kuwata, Y, Akaike, J, Ozeki, I, Sato, T, Ohmura, T

Get full text